Checkpoint sees this as a potential new treatment for patients with EGFR mutation-positive non-small cell lung cancer as olafertinib is a third-generation epidermal growth factor receptor or EGFR inhibitor.

Source: https://seekingalpha.com/article/4569044-checkpoint-therapeutics-updated-analysis?source=feed_all_articles

Engelman said there have been concerns that growth factor could potentially trigger the development of skin cancer, but that more research and proof is needed.

Source: https://www.huffingtonpost.co.uk/entry/growth-factor-is-the-latest-it-term-in-youth-boosting-skin-care-but-what-is-it_uk_65156352e4b07c60b5158f0f

Once these cells receive the mRNA, they create vascular endothelial growth factor (VEGF), a protein that helps expand the blood vessels in the placenta to reduce the mother's blood pressure and restore adequate circulation to the fetus.

Source: https://phys.org/news/2023-02-prenatal-therapy-mothers-babies-longstanding.html